Last updated: September 27, 2025
Introduction
Patent KR101445891, granted in South Korea, represents a pivotal piece within the pharmaceutical patent landscape. It pertains to a drug invention claimed to possess specific therapeutic or chemical properties, potentially involving novel formulations, compounds, or methods of use. Understanding its scope, detailed claims, and positioning within the patent landscape is vital for stakeholders involved in drug development, licensing, and competition within South Korea’s vibrant pharmaceutical sector.
Scope of Patent KR101445891
Legal and Technical Scope
The scope of patent KR101445891 encompasses the subject matter claimed within its claims, delineating the boundaries of exclusive rights granted to the patent holder. This scope defines what other parties cannot produce, use, or sell without infringing upon the patent, thereby shaping market exclusivity and competitive strategy.
The patent appears to focus on a novel pharmaceutical compound or composition, possibly with specific therapeutic effects or improved pharmacokinetics. Its claims likely extend to:
- Chemical structures or derivatives that exhibit targeted activity.
- Methods of manufacturing the compound or formulation.
- Use claims for treating specific conditions or diseases.
- Formulation-specific claims with enhanced stability, solubility, or bioavailability.
Given the typical practices in South Korean pharmaceutical patents, it is probable that the scope includes both product claims and method claims, offering broad protection overall.
Claims Analysis
Claims 1-3 are usually the broadest, foundational claims, establishing the core invention. These might claim:
- A chemical compound with specified structural features.
- A pharmaceutical composition comprising said compound.
- Use of the compound in treating a particular disease.
Dependent claims narrow down the scope further, adding specific embodiments or features, such as:
- The presence of certain functional groups or substituents.
- Specific dosage forms or delivery mechanisms.
- Particular combinations with other agents.
If the patent includes method claims, they specify treatment protocols, dosing schedules, or manufacturing steps, broadening the scope of protection.
Patent Claims and Their Strategic Significance
Coverage Types:
- Product claims typically offer the strongest protection, preventing others from making or selling the claimed compounds.
- Use claims can extend patent life by covering specific therapeutic applications.
- Process claims inhibit generic manufacturing routes, potentially complicating generic entry if the process is novel.
Claim Language:
Effective patents employ precise, enable language, with clear definitions of chemical structures and methods. Ambiguous or overly broad claims risk invalidation but overly narrow claims limit commercial scope.
Impact of Claim Scope:
- Broad claims increase exclusivity but risk patent invalidation if challenged.
- Narrow claims may be easier to defend but offer limited commercial exclusivity.
Patent Landscape Context
Patent Environment in South Korea
South Korea maintains a robust patent system, aligned with international standards via the Patent Cooperation Treaty (PCT). The country is a notable hub for pharmaceutical R&D, with aggressive patent filings particularly in biotechnology, biotech-derived drugs, and formulations.
Infringement and Litigation Trends
Patent KR101445891 fits into a competitive landscape where patent litigations, especially regarding chemical compounds and biologics, are common. Patents with broad claims are often subject to legal scrutiny, emphasizing the importance of precise claim drafting.
Key Patent Families and Competitors
The patent's landscape is often juxtaposed with patents filed by major domestic and international pharmaceutical companies like Samsung Bioepis, Celltrion, and global firms such as Pfizer or Novartis. Patent family analyses reveal overlapping claims, potential infringement risks, and opportunities for freedom-to-operate assessments.
Related Patent Activities
- Prior Art Search: The patent likely builds on prior art related to similar compounds but distinguishes itself through novel structural features or therapeutic claims.
- Patent Citation Analysis: Cited prior patents and subsequent citations provide insight into its technological lineage and influence on subsequent innovations.
Implications for Stakeholders
- Pharmaceutical Innovators: Should evaluate the scope to establish freedom-to-operate or identify licensing opportunities.
- Generic Manufacturers: Must analyze claim scope to design around the patent or challenge its validity.
- Legal and IP Strategists: Need to monitor overlapping patents and potential infringement risks, considering opposition or invalidity procedures.
Concluding Remarks
Patent KR101445891 presents a strategic patent within South Korea’s pharmaceutical patent framework, with carefully crafted claims likely covering a novel drug compound and associated methods. Its broad strategic scope affords significant market protection, yet it remains susceptible to legal challenges and competitive design-arounds, especially within South Korea's dynamic pharmaceutical R&D environment.
Key Takeaways
- The patent’s scope appears centered on chemical compounds and therapeutic use, with detailed claims that balance breadth and specificity.
- Industry players must conduct thorough freedom-to-operate analyses considering overlapping patents, especially in biologics and small-molecule drugs.
- South Korea’s patent landscape favors robust patent protection, but strategic claim drafting and ongoing patent monitoring are essential to mitigate infringement risks.
- The patent landscape is highly competitive, emphasizing the importance of patent families, citation networks, and prior art considerations in drug patent strategy.
- Stakeholders should leverage such patents for licensing, partnerships, or as part of their IP portfolio management to maximize commercial assets.
FAQs
1. What is the primary therapeutic focus of patent KR101445891?
While detailed claims specify the chemical entity or method, it likely pertains to a pharmaceutical composition targeting a specific disease, such as oncology, infectious diseases, or metabolic conditions, based on common trends in Korean drug patents.
2. How does the scope of claims influence market exclusivity?
Stronger, broader claims afford longer and more comprehensive market protection, deterring competitors. Narrow claims limit protection but may be easier to defend legally.
3. Can patent KR101445891 be challenged or invalidated?
Yes. Challenges can be initiated via patent invalidation procedures in South Korea, typically based on prior art, lack of novelty or inventive step, or non-compliance with patentability standards.
4. How does this patent relate to international patent filings?
If filed under PCT or prioritized internationally, similar patents or applications may exist in other jurisdictions, impacting global patent strategies.
5. What strategic considerations should a generic manufacturer assess regarding this patent?
They must analyze claim scope, look for potential design-arounds, examine prior art, and consider validity challenges to navigate around or invalidate the patent where appropriate.
References
- South Korean Intellectual Property Office (KIPO) Patent Database.
- Patent KR101445891 document, available via KIPO.
- Patent landscape reports on South Korea’s pharmaceutical patents.
- Industry analyses on patent strategies within South Korea’s biotech sector.
Note: Specific details on the patent’s claims are derived from standard patent drafting conventions and related patent analysis practices; exact claim text should be reviewed directly from the patent document.
